Published on:

FDA releases draft guidelines on risk mitigation strategies for pharmaceutical companies

Dow Jones Newswires has reported that the FDA released a draft of guidance on Risk Evaluation and Mitigation Strategies for drugmakers. Guidelines show how drugmakers should follow risk mitigation strategies and lists consequences for failing to do so, including fines of up to millions in some cases.

To read more about the draft guidelines.